Philadelphia Inquirer
US · 13 mins ago
Penn receives $10 million to study new treatment for ‘relentless,’ rare genetic disease with no cure
The Illinois-based nonprofit Clayco Foundation donated the funding for research on retinal vasculopathy with cerebral leukoencephalopathy, or RVCL.
Do you trust Philadelphia Inquirer?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!